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1. Introduction
The increase demand of environmental concerns over 
non-biodegradable polymers have been driving forward 
with the development of biodegradable polymers, due to 
its cost effective availability and biodegradability. Apart 
from environmental friendly these polymers also possess 
properties like mucoadhesiveness, film-forming ability and 
easily tailored to impart stimulus responsive activation. 
Such properties allow their wide range of application in 
pharmaceutical industry. Ophthalmic delivery system is one 
of the challenging domains of formulation and development 
due to lacrimal drainage, tear dilutions, non productive 
absorption and relatively less permeable through the 
epithelial cells of eye (Lallemand, Felt-Baeyens, Besseghir, 
Behar-Cohen & Gurny, 2003). To overcome such difficulties 
in ophthalmics use of certain polysaccharides and their 
modifications are proven to be a promising approach(Sharma 
& Batra, 2019; Sharma, Sinha, Sarwal & Shukla, 2018; 
Sumit, Shikha, & Rayasa, 2012).  Xanthan gum, a natural 
occurring biodegradable exo-polysaccharide extracted from 
bacterium Xanthomonas campestris is widely accepted as one 
of the potential polysaccharide in ophthalmic. Xanthan gum 
is discovered in the late 1960’s by the team of United States 
Food and Drug Administration (USDA) researchers.  It is 
widely used in many important preparations ranges from 
food, cosmetics, oil extracting industries and pharmaceutical 
products. Xanthan gum has a broad range of operations that 
makes it substance of first choice in ophthalmic preparations 
as thickening agent, suspending agent or as stabilizing agent 
to stabilize the pH of the preparation to make it compatible 
with the pH of target site (Benita & Nassar, 2016). The 
development of an ocular dosage form containing xanthan 
gum is capable of interacting with mucin in the precorneal 
area which is a challenge, because limited number of patients 
has the acceptability in response with the highly viscous 
preparations. This is due to the low concentration of mucin 
at precorneal site and high ionic strength lead to organization 
of xanthan gum structure. This results in limited interaction 
of polymer with heterotypic junctions. In this review article 
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we are discussing the physicochemical properties of xanthan 
gum in different conditions required for ideal ophthalmic 
delivery system. Also, the chemical modifications of xanthan 
gum reported in literature with respect to improvising its 
practical applications in ophthalmic.
2. Chemistry of Xanthan Gum
Xanthan gum is a biodegradable natural polymer obtained 
from bacterium Xanthomonas campestris on cabbage plants. 
Xanthan gum is a trisaccharide compound having a large 
molecular mass. The basic chain present in xanthan gum 
is 1, 4 β-D-Glucose residue. Xanthan gum consists of 
D-glucosyl, D-glucuronyl and D-mannosylacid residues 
with molar ratio 2:1:2 (Dário, Hortêncio, Sierakowski, 
Neto, & Petri, 2011). The secondary structure of xanthan 
gum consists of a right-handed, five-fold helix with a rise per 
backbone disaccharide residue, i.e. five-fold helix. It gives 
more strength and holds the structure in aligned and proper 
manner. Production of xanthan gum is raised commercially 
on global level as emergent excipient for ocular drug delivery 
in eye.  Xanthan gum for their tremendous advantages 
currently isbeing used as preferred additive for the various 
ophthalmic preparations for their properties. Along with 
ocular drug delivery xanthan gum has diverse and wide range 
of contribution in various edible and cosmetic products. 
Due to saccharide in nature it has unique advantage to 
enhance viscosity of the solution; others are lubricant and 
stabilizing agent. Xanthan gum is soluble in both hard and 
soft water. Formation of lumps gets started when directly 
added to water so it is mandatory to pass the xanthan gum 
from aggregation process to reduce the size of particles and 
maintain the uniformity of the solution. It attains solution 
state when placed under elevated temperature. At initial 
or rest state when no external shear is applied hydrogen 
bonding holds xanthan gum in its limited boundary. 
Number of modifications would be done by implicating 
different chemical processes to increase the rheological 
characters of xanthan gum such as carboxymethylation, 
microwave-assisted, chemoenzymatic and plasma assisted 
chemical grafting to alter physicochemical properties. It also 
exerts bioadhesive property and become the main advantage 
over the drawback of limited absorption in ophthalmic 
preparations. Bioadhesion is tendency of substance to make 
a strong linkage with biological tissues and prevent loss due 
to lacrimal drainage. In modern approaches to ocular drug 
delivery the first priority of any pharmaceutical industry 
is to ensure the safety of preparations along with their 
efficacy. In currently applied methods the implication of 
synthetically derived polymers as additives along with active 
chemical ingredients is great combination for ophthalmic 
preparations.   
3. Physiochemical Behaviour of Xanthan Gum
3.1. Effect of Temperature
Temperature is one of the significant parameter which affects 
the physiochemical properties of the xanthan gum. Change 
in temperature from optimum range leads to change in 
conformation from ordered to disordered state. In a report 
submitted by Brunchi and co-workers revealed changes 
occurred in the electrokinetics and the flow behavior on the 
aqueous xanthan gum when dissolved at high temperature. 
This study reveals that increase in the viscosity of xanthan 
gum due to reshaping in the conformations of particles from 
ordered to disordered takes place at concentration range of 
0.1 – 0.3 g/dl with elevation in temperature upto 40°C. The 
rational statement given by the author for the increase in 
viscosity with respect to temperature is imbalance between 
Coulombic and non-Coulombic electrostatic forces of 
interactions (Brunchi, Avadanei, Bercea, & Morariu, 2019).
3.2. Effect of pH
Hydrogels are one of the promising approaches for the better 
and efficacious results in the ocular drug delivery. Hydrogels 
formed by crosslinking process where it involves addition of 
physical or chemical cross linking agents for polymerization 
of their subunits. Swelling ratio is the characteristic property 
of hydrogels which is greatly influenced by pH. For instance, 
in hydrogels based on xanthan gum with increase in pH 
particularly above 6.5, swelling ratio increases. This effect 
is due to prominent electrostatic repulsions within the gel 
crosslinked structure. Moreover, deprotonation of unreacted 
hydroxyl groups and ester bond hydrolysis in alkali medium 
are also contributes to this effect (Bueno, Bentini, Catalani, 
& Petri, 2013). 
3.3. Effect of Concentration
In ophthalmic preparations, the viscosity of upto 20 mPa. S 
is considered to be optimum and tolerant. It is observed that 
xanthan gum concentration follows linear relationship with 
viscosity at low concentrations range upto 1.0 %. Also at higher 
concentration of above 1.0% the aqueous dispersion of xanthan 
gum shows gel like consistency at normal state (Zatz & Knapp, 
1984). In a study at a concentration range of 0.2, 0.6 and 1.0% 
of xanthan gum at a shear rate of 300 s-1 the viscosity ranges 
approximately as 9.5, 36 and 120 mPa. S respectively. The 
viscosity less than 20 mPa. S is optimum in case of Newtonian 
and pseudoplastic systems for ocular delivery. Higher viscosities 
are not suitable for use in ophthalmic with Newtonian and 
pseudoplastic systems. In addition to this, the systems show 
viscoelastic behavior the viscosity of around 150 mPa. S are 
considered optimum for ophthalmic use (Ceulemans, Vinckier 
& Ludwig, 2002). 
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4. Pharmaceutical Applications
4.1. Xanthan Gum as Mucoadhesive
Mucoadhesion is the phenomenon which holds two 
materials together by managing interfacial forces between 
them to enhance the time of retention of the active substance 
and prolongs the therapeutic effect. Mucoadhesion is a 
significant approach which overcomes certain drawbacks 
of traditional drug delivery such as binding with lachrymal 
protein, tear turnover, low precorneal penetration and non-
effective absorption. Alteration of certain physiochemical 
factors of polymer such as concentration, molecular 
conformation, molecular mass imposes significant impact 
on mucoadhesive behavior of the polymer with mucin. 
Mucin is a glycosylated protein present in eyes at very low 
concentrations (Mann, Campbell & Tighe, 2016).
In a report, submitted by Morsi and co-workers 
evidenced the use of xanthan gum to increase the 
mucoadhesive property of in situ nanoemulsion gelling 
system. In this experimental study, gellan gum was used in 
combination with certain polymers (xanthan gum, HMPC 
K4M and carbopol 940) for the preparation of in situ 
gelling system. For the preparation of aqueous formulation, 
deionized water was used and polymeric combination 
(gellan/carbopol 940, gellan/xanthan and gellan/HPMC) 
were dissolved in it. This process was done with continuous 
heating for 20 min at 90°C. Then acetazolamide loaded nano 
emulsion was added into the above mentioned aqueous 
polymeric dispersion. The mucoadhesive strength of finished 
product comprising variable polymeric concentrations (0.2, 
0.4 and 0.6% w/w) with 0.3% w/w fixed concentration of 
gellan gum was determined. The pattern of mucoadhesive 
behavior at concentration 0.2% was carbopol 940 > xanthan 
gum > HPMC. Further increase in concentrations results 
in change in relative mucoadhesive behavior of gellan gum 
except carbopol. The mucoadhesive behavior of the carbopol 
was neither increased nor decreased when the strength was 
increased to 0.4 % and 0.6%. The order of mucoadhesive 
behavior after increase in strength are xanthan gum > 
carbopol > HPMC. This study evidenced the mucoadhesive 
behavior is due to induced ionic charge on the side chain of 
the polymer. The charged group on the side chains makes 
its molecule enlarged due to its electrostatic repulsive force. 
This leads to the formation of hydrogen bonding and 
makes the molecule align by formation a helical structure 
which holds water in the molecule and results increase the 
viscosity of in situ gelling system. Then further increased in 
concentration enhances the molecular bulk and makes the 
side chains more interlinked and enhances the viscosity of in 
situ gelling system as compared to other polymers (Morsi, 
Ibrahim, Refai & El Sorogy, 2017).
In another study conducted by Ahmedand co-workers 
evidence use xanthan gum in combination with hydroxyl 
propyl methyl cellulose (HPMC E50LV) to enhance the 
mucoadhesion and release time of in situ gel preparation of 
brimonidine tartrate. Concentration of xanthan gum used 
in the experiment was (0.21%). For the preparation of in 
situ gels, borate buffer solution was taken and heated up to 
70°C after the inclusion of sufficient quantity of polymer. 
Addition of drug was followed after the addition of required 
quantity of xanthan gum with slight heating and mixed 
completely in the solution. In the above prepared solution 
phenylethyl alcohol and HPMC E50 LV were added by 
giving the exposure of magnetic stirring. Then final product 
was sterilized by applying autoclaving technique. Experiment 
was performed on the basis of 23 factorial design protocol. 
After the completion of whole study it was evidenced that 
xanthan gum at optimum concentration (0.21%) does not 
have any interaction with the drug and increase in sustained 
release of drug was observed up to 10 hours (Ahmed & 
Goli, 2018).
4.2. Xanthan Gum as a Stabilizer
Ocular drug delivery demands amphiphilic characteristics 
to get absorbed quickly for good bioavailability and tissue 
distribution. As the barriers in ophthalmic is the aqueous 
layer of lacrimal glands followed by lipid layer of meibomian 
glands. Drugs which are highly hydrophilic or lipophilic 
in nature exert insufficient bioavailability and tissue 
distribution through ocular route. Therefore, emulsions are 
one of the promising drug delivery systems to meet the prime 
requisites for efficient ocular drug delivery. But emulsions 
have stability issues due to coalescence which ultimately 
lead to phase separation. Moreover, suspensions are also 
commonly exploited for ophthalmic formulations. This 
delivery system has a stability issue due to cake formations 
which ultimately lead to phase separation. Natural polymers 
like xanthan gum for their magnificent effect to modify the 
rheological characters of pharmaceutical formulations by 
resulting the change in shear thinning property and change 
in movement kinetics when used in optimum concentration 
range are commonly used in ophthalmic. 
There are certain problems which make the drug 
less bioavailable such as creaming during storage time, 
gravitational separation, coalescence, flocculation, phase 
inversion and thermostability. Xanthan gum in a variety 
of formulations such as emulsions, in situ gelling with 
certain modifications are used as stabilizers to enhance the 
bioavailability and stability of ophthalmic formulations. 
Xanthan gum with certain chemical modifications is proven 
to minimize the interfacial tension by acquiring amphiphilic 
characteristics and enhance the viscosity of continuous 
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phase. This reduces the particle movement in between 
the system and prevents coalescence as well as settling of 
colloidal particles.
In a report, submitted by Céline and co-workers 
hydrophobically modified xanthan gum of optimum 
concentration range was taken to prepare oil-in-water 
emulsion. Grafting of polysaccharide was done with octyl 
residue on its carboxylic group through peptide coupling 
reaction. Hydrophilic solutions of hydrophobically 
modified xanthan with concentration ranges from 0.125% 
to 1.125% w/w were prepared with continuous overnight 
stirring at 20 to 250C. The author concluded that at low 
concentration of modified xanthan gum i.e. from 0.05 to 
0.1% w/w emulsion was observed to be unstable. A phase 
separation with non uniform oil droplet size was observed 
rendering the emulsion as unstable on storage. Furthermore, 
on increasing the concentration of modified xanthan gum 
uptill 0.2% w/w a homogenous emulsion with uniform 
droplet size was observed (Céline et al., 2018). 
In another study, submitted by Krstonošić and co-
workers increased concentration of xanthan gum 0.01%, 
0.08% up to 0.12% was used to overcome the creaming 
problem in emulsion. At initial concentration of xanthan 
gum 0.01% w/w lipophilic droplets phase got flocculated 
and clear separated biphasic system is formed. Aggregation 
of oil droplets was observed at the top as well as at the 
bottom of the aqueous continuous system. The strength 
of interconnected network of droplets was decreased when 
concentration of gum was increased from 0.04% to 0.08% 
w/w and got reunited due to certain factors such as Brownian 
motion, gravitational force. Further increased concentration 
of xanthan gum up to 0.12% leads to the emergence of 
critical viscosity stage and results in the intellectual disability 
of creaming by deceleration the establishment of network 
of droplets. In addition to this, xanthan gum enhanced 
the aqueous phase stability of the emulsion by creating the 
uniformity in the size distribution of droplets with enhanced 
interfacial surface area and also decrease the flow kinetics of 
the emulsion (Krstonošić et al., 2009). 
4.3. Xanthan Gum as Viscosifier
In current days the approaches and demands of the ocular 
treatments have become more advanced targeting to the 
required site. Nano particle drug delivery is promising 
approach in various dosage forms (suspensions, emulsions 
and ointments) to produce optimum effects. In ocular 
delivery leading barriers which restrict the drug for its 
action, are less corneal retaining time, rapid eye blinking, 
blood retinal permeation and low penetrating tendency. To 
maintain the viscosity in optimum range of the formulation 
in ocular delivery and to achieve the optimum effect of 
prepared formulation a range of 15-150mPa s has been 
defined. In this optimum viscosity range penetration of 
drug from corneal layer is maximum and there is decreased 
frequency of administration of the drug. Sudden increase in 
viscosity from the optimum range exerts negative effect such 
as blurring of vision and increase the residence time from 
the required time range in deeper tissues of the eye. 
In a report submitted by Ceulemans et al. study 
the effect of viscosity when xanthan gum of optimum 
concentration (1% w/v) was mixed with mucin ranging 
between 8% and 16% for the optimum rheological 
characteristics. When the mixture got cooled after the 
heating, changes took place and the conformation changed 
from ordered to disordered state and the whole sample 
could not attain its initial helix structure. This resulted 
in increase in formation of secondary bond or physical 
entanglement between mucin and xanthan gum as a result 
increasing its intrinsic viscosity (Ceulemans, Vinckier & 
Ludwig, 2002).
4.4. Xanthan Gum as Supportive Agent for 
Synthetic Polymers
Instant drainage and secretion of lachrymal fluid are the 
major problems associated with ophthalmic delivery. 
Synthetic polymers like poloxamer are observed to be 
promising material with stimuli responsive properties 
against temperature to overcome from aforesaid 
physiological considerations. At specific concentration 
the aqueous dispersion of these polymers shows 
reversible sol to gel transformations under the influence 
of temperature. One of the limitations of poloxamer gel 
is their low mucoadhesive property. To overcome this 
type of disadvantages xanthan gum is used as supportive 
agent.  Bhowmik and co-workers submitted a report to 
show the effect of xanthan gum used in combination with 
guar gum in optimum ratio on in situ gelling poloxamer 
system. This study revealed the formation of poloxamer 
gel when temperature was increased up to physiological 
temperature 37°C in an optimum concentration range 
of 18-20%. When concentration decreased from the 
optimum concentration there was no formation of gel. 
The study revealed that the combination of xanthan gum 
and guar gum in ratio of 3:7 induced the formation of gel 
(Bhowmik et al., 2013).  
5. Chemical Modification of Xanthan Gum
As we discussed above that xanthan gum is used for 
diverse applications such as stabilizing agents, thickening 
agent, bioavailability enhancer and as a commercial 
pharmaceutical aid, there are some limitations associated 
with it. Some barriers such as slow dissolution rate, low 
molecular strength, aggregates the gum and leads to the 
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formation of the lumps and delays the optimum therapeutic 
index in the required time. So, to overcome these barriers, 
certain chemical modifications such as carboxymethylation, 
grafting, copolymerization of xanthan gum is done (Ahuja, 
Kumar & Singh, 2012).
5.1. Cold Plasma Treatment
Cold plasma treatment is one of the techniques explored 
for chemical modifications of xanthan gum. It is a non 
thermal technique which is used to inactivate the microbial 
action that is due to the exposure of xanthan with free 
radicals, electric field, UV light and other chemically excited 
species. It affects the physiological and thermal properties 
of xanthan gum. It also shows grateful impact on secondary 
and tertiary structure of the xanthan gum. At the same time 
it has no effect on the nutrition composition of xanthan 
which includes moisture, crude ash, and nitrogen free 
extracts. Outcomes of cold plasma treatment is decrease in 
bulk, tap density and compressibility index with an increase 
in porosity, Hausner’s ratio and angle of repose of xanthan 
gum. Other results of cold plasma treatment are change in 
acid, hydroxyl value and pH of xanthan gum.
5.2. Formaldehyde as a Dissolution Enhancer
For the better efficacy and optimum xanthum gum 
therapeutic response more dispersibility of excipient in the 
formulation is one of the essential demanding approaches. 
One of the limiting properties of xanthan gum is its slow 
dissolution rate.
In a study performed by Suand co-workers, effect of 
formaldehyde on the dissolution rate of xanthan gum was 
examined. The study showed that purified modified gum had 
rapid dissolution rate over xanthan gum alone. The optimum 
increase in the viscosity was observed in initial time range 0-4 
seconds. The sudden increase in the swelling and dissolution 
due to change in molecular conformation with addition of 
formaldehyde was observed. This was attributed to limit 
the intermolecular bonding and ordered-disordered state in 
polymer (Badwaik et al., 2013; Su et al., 2003).
5.3. Etherification of Xanthan Gum
For the optimum therapeutic and rheological responses in 
ocular drug delivery modification in the basic structure of 
xanthan gum is one of the promising approach. Xanthan 
gum when dissolved in aqueous medium exerts limited 
swelling capacity due to the formation of gelatinous layer 
which results in the slow hydration of polymer and restricts 
the rate of dissolution. Carboxymethylation is one of 
the currently used techniques for the modification of the 
xanthan gum in order to improve polymer dissolution and 
mucoadhesion. Carboxymethylation is done by attachment of 
monochloracetic acid by substituting hydroxyl group attached 
on the main chain of the xanthan gum. This substitution of 
hydroxyl group is known as etherification and is basically the 
process of dehydration of hydroxyl group when polysaccharide 
reacts with carboxymethyl group. For the customization of the 
release profile and to enhance the mucoadhessive property of 
the xanthan gum, carboxymethylation is done (Hamcerencu, 
Popa, Riess & Desbrieres, 2019).
In another report submitted by Ahuja and co-workers, 
carboxymethylation of xanthan gum was done by reacting 
monochloroacetic acid with xanthan gum. This study 
revealed that carboxymethylated xanthan gum resulted in 
minimizing the size of particles as compared to pure xanthan 
gum and change in the shape of particle from irregular to 
spherical. Spherical particles have certain advantages over 
irregular particles as it enhances the flow property of the 
ophthalmic preparations, increases the rate of hydration and 
rapid dissolution of xanthan gum (Ahuja et al., 2012).
5.4. Grafting of Xanthan Gum
Grafting is the process where different blocks are connected 
to the main chain of the host polymer as side chains. All 
these blocks have different characteristic properties as 
compare to the main chain character. Grafting reaction 
is based on copolymerization of two or more replicating 
monomeric units The principle based on grafting 
polymerization is the cohort of free radicals on the host 
polymer, and promote polymerization of monomers into 
free radical sites resulting into graft copolymerization. These 
copolymers are differentiated as random copolymers, block 
copolymers, alternate copolymers and graft copolymers. 
Grafting technique is used to modify the features of the host 
polymers such as solubility, permeability capacity, reactivity, 
elasticity and temperature. In recent centuries, grafting 
copolymerization technique has expanded based on the 
modification of natural polysaccharides. Different types of 
grafting techniques include – chemical method, microwave 
radiation- induced grafting, enzymatic grafting and plasma- 
initiated grafting. Chemical method involves chemical 
redox initiators (Lewis acids, metal carbonyl, strong bases 
etc.) to produce free radicals or active sites on the host 
polymer. Microwave radiation – induced grafting is most 
convenient form of grafting. It involves active sites or free 
radicals when electromagnetic radiation is passed through 
the host polymer. This technique maintains the highest 
purity, subsequently prevents contamination, toxic solvents, 
reduces the time of reaction and provides high yields. In 
enzymatic grafting, an enzyme induces a chemical grafting 
on the host polymer. The grafting of natural polysaccharides 
with the help of enzyme has been used in large number of 
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industries. Certain organic chemicals used for the grafting of 
xanthan gum are maleic anhydride, acrylic acid and acryloyl 
chloride (Hamcerencu et al., 2019; Kulkarni et al., 2019).
5.5. Grafting with Acrylamide
Modification of the xanthan gum through hydrolysis and 
grafting it with acrylamide is usually done to improve 
its functional characteristics with enhancing range of 
applicability. For instance, poly (N-isopropyl acrylamide) 
based hydrogel has been extensively studied as an 
intelligent polymeric matrix for use in biotechnology and 
bioengineering. It is also investigated as biocompatible for 
human use. 
Badwaik and co-workers prepared the Poly amalgamate 
of acrylamide-grafted-carboxymethyl xanthan gum 
by liquefying dry carboxymethylated xanthan gum of 
concentration 4-24 g/dm-3 in distilled water. The study 
revealed the enhancement in the rheological characteristics 
of the blend due to increase in the number of active site when 
the concentration of the carboxymethylated xanthan gum 
was taken in the optimum range of 4 -16 g/dm-3. Further 
increase in the concentration made the blend more viscous 
and retarded the motion of particles. Study concluded that 
the intrinsic viscosity of the carboxymethylated xanthan 
gum was decreased due to the formation of polyacrylamide 
at hydroxyl group. This in turn, decreased the intrinsic 
viscosity and hence the flow becomes non-Newtonian. 
Study also evidenced the increase in the thermal stability 
of the polyacrylamide carboxymethylated xanthan gum 
as compared to carboxymethylated xanthan gum with 
reduction in semi crystalline nature of particles due to 
hindrance in the ordered structure (Badwaik et al., 2016). 
5.6. Grafting with acryl Acid 
Multiple acrylic acid units have been prepared and 
investigated for their ability to act as controlled release 
vehicles in ophthalmic drug delivery especially delivering 
to corneas. In sustainable drug delivery, thermoresponsive 
in situ gels have been utilized to improve ocular absorption 
because of their lower critical solution temperature 
(Rosalam & England, 2006). Poly-(N-isopropyl acrylamide) 
(PNIPAAm)-based thermoresponsive copolymers have been 
extensively studied owing to the thermally induced phase 
transition of PNIPAAm at 32°C, which is close to the 
physiological temperature.
The study conducted by Hajikhani and co-workers 
evidenced the use of N, N′-hexane-1, 6-dilbisprop-2-
enamide or 1, 4-butandioldimethacrylate as cross-linking 
agent which assisted the formation of semi- interpenetrating 
polymer network by entrapping the polysaccharide inside 
the crosslink agent and exert their action on acrylic acid/
xanthan gum biopolymer complex. The study evidently 
confirms the increase in stability of xanthan gum in different 
phase. Formation of inter penetrating networks was found 
to be the reason for improved mechanical strength and 
ultimately contributing to the stability of formulation 
(Hamcerencu et al., 2019; Kulkarni et al., 2019).
Conclusion
Many attempts have been made to improvise the ophthalmic 
formulations with respect to increasing bioavailability 
and imparting stability to the emulsions and suspensions 
for longer shelf life. Xanthan gum provides numerous 
opportunities because of multiple functionalities. Providing 
with different possibilities of conjugation with numerous 
ligands and structural modifications has led xanthan gum as 
potential biopolymer for ophthalmic applications. Several 
detailed evidence based studies have been done on xanthan 
gum describing the characteristic behavior of xanthan 
gum in various physiological conditions. In our opinion, 
xanthan gum is an ideal biopolymer for controlled release, 
stabilizer for emulsions and suspensions, as dissolution 
enhancer and improving bioavailability for ophthalmic 
preparations.
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